Podimetrics developed the FDA-cleared SmartMat™, an easy-to-use at-home mat that detects temperature changes in patients’ feet and alerts the company’s clinical and patient support team. The SmartMat is paired with integrated clinical care services aimed at preventing amputations in complex diabetic patients. Podimetrics partners with regional and national health plans and at-risk providers, including the Veterans Health Administration, to drive adoption. The company reports high patient engagement rates and emphasizes keeping vulnerable populations healthy in their homes. Founded in 2011 and based in Somerville, Mass., and Menlo Park, Calif., Podimetrics plans to expand its commercial operations. It received growth capital to support that expansion. Podimetrics develops the FDA-cleared SmartMat™ and integrated clinical care services aimed at preventing amputations and other complications in complex diabetic patients. The company partners with regional and national health plans and at-risk providers, including the Veterans Health Administration, to deliver its monitoring and care services. Podimetrics plans to use the new funding to hire and build out product development and research teams. It also intends to expand the breadth of services delivered by its nurse support team. The company was founded in 2011 by Jon Bloom, MD, who serves as CEO, and is based in Somerville, Massachusetts. The article does not disclose operating metrics such as revenue or user counts. Podimetrics offers a remote physiologic monitoring solution centered on its FDA-cleared SmartMat, which patients stand on for 20 seconds daily so data are sent to a care management team. The company partners with payers and at-risk providers, including the Veterans Health Administration, and its services are used in more than 40 VA medical facilities. Podimetrics reports more than 300% growth in the first half of 2020 versus the prior year and earns high patient engagement rates. The SmartMat is manufactured in Massachusetts and has the American Podiatric Medical Association Seal of Approval. Podimetrics was founded in 2011 by a physician and engineers from MIT and Harvard and is headquartered in Somerville, MA. With new advisory board additions, the company is expanding its commercial presence to reach more at-risk patients in the VHA and private payer markets. Podimetrics offers a preventive care solution for diabetic foot ulcers consisting of an FDA-cleared, cellular-connected SmartMat paired with a care management team that triages concerning findings. High-risk patients place their feet on the mat for about 20 seconds daily and the device automatically transmits data for review. The company delivers this service on behalf of payers and at-risk providers. Podimetrics closed a $13.4M Series B to fund its growth. Management intends to use the proceeds to accelerate adoption within the Veterans Affairs health care system and among commercial payers nationwide. The company is focused on scaling deployment and payer relationships to expand monitoring and early intervention. Podimetrics builds a bathroom-mat sensor system that scans patients' feet, sends blood-flow data to the cloud, and uses algorithms to analyze longitudinal trends and left-right comparisons to detect pre-ulcers. When the algorithms detect a developing ulcer, the system sends alerts to the patient and their doctor to prompt early intervention. The device takes about 30 seconds to use each day. The company graduated from Rock Health’s healthcare accelerator. Podimetrics says it will use recent investment proceeds to develop additional products to help people with diabetes. Since October the company has raised $2.5 million, per the article.

Total raised

$89M

Funding rounds

5

Latest round

Debt Financing

Latest activity

Nov 2022